EA200602161A1 - BIOLOGICALLY ACTIVE ASTAXANTIN-CONTAINING SUBSTANCE - Google Patents
BIOLOGICALLY ACTIVE ASTAXANTIN-CONTAINING SUBSTANCEInfo
- Publication number
- EA200602161A1 EA200602161A1 EA200602161A EA200602161A EA200602161A1 EA 200602161 A1 EA200602161 A1 EA 200602161A1 EA 200602161 A EA200602161 A EA 200602161A EA 200602161 A EA200602161 A EA 200602161A EA 200602161 A1 EA200602161 A1 EA 200602161A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- biologically active
- astaxanthin
- substance
- content
- components
- Prior art date
Links
- 239000000126 substance Substances 0.000 title abstract 5
- 235000013793 astaxanthin Nutrition 0.000 abstract 4
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 abstract 3
- 239000001168 astaxanthin Substances 0.000 abstract 3
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 abstract 3
- 229940022405 astaxanthin Drugs 0.000 abstract 3
- 230000003078 antioxidant effect Effects 0.000 abstract 2
- MQZIGYBFDRPAKN-UWFIBFSHSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-UWFIBFSHSA-N 0.000 abstract 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 abstract 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 abstract 1
- FMKGDHLSXFDSOU-BDPUVYQTSA-N Dienon-Astacin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(=CC1(C)C)O)C=CC=C(/C)C=CC2=C(C)C(=O)C(=CC2(C)C)O FMKGDHLSXFDSOU-BDPUVYQTSA-N 0.000 abstract 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 abstract 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 abstract 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 abstract 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 abstract 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 abstract 1
- RASZIXQTZOARSV-QISQUURKSA-N astacene Chemical compound CC=1C(=O)C(=O)CC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)C(=O)CC1(C)C RASZIXQTZOARSV-QISQUURKSA-N 0.000 abstract 1
- 235000013734 beta-carotene Nutrition 0.000 abstract 1
- 239000011648 beta-carotene Substances 0.000 abstract 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 abstract 1
- 229960002747 betacarotene Drugs 0.000 abstract 1
- 230000000975 bioactive effect Effects 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 229940088623 biologically active substance Drugs 0.000 abstract 1
- 235000012682 canthaxanthin Nutrition 0.000 abstract 1
- 239000001659 canthaxanthin Substances 0.000 abstract 1
- 229940008033 canthaxanthin Drugs 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 235000012680 lutein Nutrition 0.000 abstract 1
- 239000001656 lutein Substances 0.000 abstract 1
- 229960005375 lutein Drugs 0.000 abstract 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 abstract 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000005457 optimization Methods 0.000 abstract 1
- -1 semi-astacene Chemical compound 0.000 abstract 1
- 239000008247 solid mixture Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 abstract 1
- 235000010930 zeaxanthin Nutrition 0.000 abstract 1
- 239000001775 zeaxanthin Substances 0.000 abstract 1
- 229940043269 zeaxanthin Drugs 0.000 abstract 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/40—Colouring or decolouring of foods
- A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
- A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
- A23L5/44—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
Изобретение относится к области биологически активных препаратов и предназначено для изготовления биоактивных акстансантиносодержащих веществ с высокой антиокислительной активностью. Решается задача наиболее рациональной оптимизации содержания компонентов биологически активных препаратов для достижения тем самым технического результата в отношении повышения биологической активности вещества, в частности, антиокислительной его эффективности. Это обеспечивают биологически активным астаксантиносодержащим веществом, изготовленным в виде жидкой или твердой смеси гомогенно распределенных в ней компонентов, включающим астаксантиносодержащий комплекс бета-каротина, кантаксантина, астацена, полуастацена, лютеина, зеаксантина, а также растворителей, вспомогательных компонентов и инертных наполнителей. Предложена система неравенств, взаимосвязывающих основные компоненты биологически активного вещества, сформированная таким образом, что для оптимизации его состава содержание каждого нового компонента в веществе выбирают с учетом и в зависимости от фактического или задаваемого содержания С всего астаксантиносодержащего комплекса, а также от величины С-содержания транс-астаксантина в астаксантиносодержащем комплексе.The invention relates to the field of biologically active preparations and is intended for the manufacture of bioactive Akstanisantino substances with high antioxidant activity. The problem of the most rational optimization of the content of the components of biologically active preparations is solved to thereby achieve a technical result with respect to increasing the biological activity of a substance, in particular, its antioxidant effectiveness. This is ensured by a biologically active astaxanthin-containing substance made in the form of a liquid or solid mixture of components homogenously distributed in it, including an astaxanthin-containing complex of beta-carotene, canthaxanthin, astacene, semi-astacene, lutein, zeaxanthin, as well as solvents, auxiliary components and inert fillers. A system of inequalities is proposed that interconnect the main components of a biologically active substance, formed in such a way that the content of each new component in the substance is chosen to optimize its composition, taking into account and depending on the actual or specified content C of the entire astaxanthine-containing complex, as well as on the value of the C content of trans -astaxanthin in an astaxanthin-containing complex.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2004119084/13A RU2261631C1 (en) | 2004-06-24 | 2004-06-24 | Bioactive astaxanthin-containing substance with antioxidant activity |
PCT/RU2005/000342 WO2006004458A1 (en) | 2004-06-24 | 2005-06-23 | Biologically active astaxanthin-containing agent |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200602161A1 true EA200602161A1 (en) | 2007-04-27 |
Family
ID=35783160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200602161A EA200602161A1 (en) | 2004-06-24 | 2005-06-23 | BIOLOGICALLY ACTIVE ASTAXANTIN-CONTAINING SUBSTANCE |
Country Status (3)
Country | Link |
---|---|
EA (1) | EA200602161A1 (en) |
RU (1) | RU2261631C1 (en) |
WO (1) | WO2006004458A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2327483B1 (en) * | 2007-11-24 | 2010-08-12 | Biogolden Slu | FOOD CONSERVATION PROCEDURE. |
RU2551578C2 (en) * | 2013-04-29 | 2015-05-27 | Сергей Константинович Панюшин | Bulk food product |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2148941C1 (en) * | 1998-12-28 | 2000-05-20 | Московский Государственный Университет пищевых производств | Method of preparing biologically-active food additive |
US20030206972A1 (en) * | 2000-10-13 | 2003-11-06 | Babish John G. | Compositions containing carotenoids and tocotrienols and having synergistic antioxidant effect |
JP4527938B2 (en) * | 2002-07-23 | 2010-08-18 | オルビス株式会社 | Orally administered composition for antioxidant |
-
2004
- 2004-06-24 RU RU2004119084/13A patent/RU2261631C1/en not_active IP Right Cessation
-
2005
- 2005-06-23 EA EA200602161A patent/EA200602161A1/en unknown
- 2005-06-23 WO PCT/RU2005/000342 patent/WO2006004458A1/en active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
RU2261631C1 (en) | 2005-10-10 |
WO2006004458A1 (en) | 2006-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL170866A (en) | Stable liquid formulation of low turbidity comprising an anti ige antibody | |
NO20044959L (en) | Oil-soluble compounds | |
Fatani et al. | Lutein dietary supplementation attenuates streptozotocin-induced testicular damage and oxidative stress in diabetic rats | |
BR112012022223A8 (en) | CONCENTRATED PROTEIN FORMULATION, USE AND PREPARATION METHOD | |
CL2010000823A1 (en) | Anti-cd-20 antibody with apoptotic activity; polynucleotide, vector and host cell expressing the antibody; pharmaceutical composition that includes it; uses in the preparation of a medicament to treat cancer or an autoimmune disease; method for producing said antibody (div. sol. No. 2246-06). | |
EA201300875A1 (en) | CAROTINOID PARTICLES AND THEIR APPLICATION | |
CO4750643A1 (en) | STABLE FORMULATION OF INSULIN CONTAINING L-ARGININ AND PROTAMINE | |
de Araújo et al. | Essential oils components as a new path to understand ion channel molecular pharmacology | |
EA201001283A1 (en) | COMBINATION OF VITAMIN D AND 25-HYDROXIVITAMINE D3 | |
AR047928A1 (en) | TETRAHYDROPIRIDOINDOL DERIVATIVES | |
ECSP034772A (en) | MCH ANTAGONISTS AND ITS USE IN OBESITY TREATMENT | |
BR0209960B1 (en) | Stabilized carotenoid compositions, their preparation process and their use, as well as food, vegetable shortening and margarine | |
EA200900272A1 (en) | COMBINATIONS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH CELL PROLIFERATION, MIGRATION OR APOPTOTIS OF MYELOMA CELLS OR ANGIOGENESIS | |
AR029851A1 (en) | NEW PEPTIDES AS INHIBITORS OF NS3-SERINA PROTEASA DEL VIRUS DE HEPATITIS C | |
RU2007125126A (en) | COMPOSITION FOR REDUCING THE NUMBER OF FAT IN THE BODY | |
ECSP066617A (en) | FUNGICIDE BLENDS TO FIGHT RICE PATHOGENS | |
UY33719A (en) | DERIVATIVES OF 2,3-DIHYDROIMIDAZO [1,2-C] QUINAZOLINA SUBSTITUTED WITH AMINOALCOHOLES THAT ARE USEFUL TO TREAT HYPERPROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS | |
BRPI0513622A (en) | application of self-emulsifying combinations (seeds) of lipid excipients, surfactants; pharmaceutical composition containing an active ingredient and a self-emulsifying combination (seeds) of lipid excipients, surfactants; and process for the preparation of self-emulsifying combinations (seeds) of lipid excipients, surfactants | |
EA200702486A1 (en) | ANTI-VIRUS, ANTI-TUMOR OR ANTI-PARASITIC PHARMACEUTICAL COMPOSITION AND ITS APPLICATION | |
AR049518A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING A SILICONE AGENT AND TWO SOLUBILIZED ACTIVE PRINCIPLES | |
AR052787A1 (en) | PROCESS TO PREPARE FORMULATIONS OF LIPOFILIC ACTIVE SUBSTANCES THROUGH ATOMIZATION LIOPHILIZATION | |
SI2090164T1 (en) | A rodenticide bait based on a synergetic association of anticoagulant active ingredients | |
EA200901365A1 (en) | STABILIZED PHARMACEUTICAL COMPOSITION CONTAINING PREGABALIN | |
UY28271A1 (en) | CHEMICAL COMPOUNDS | |
WO2015023553A3 (en) | Modulation of disease by administration of sulfur-containing, amino acid-specific small molecules |